Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Top Cited Papers
- 1 February 2020
- journal article
- review article
- Published by Elsevier BV in The Lancet Haematology
- Vol. 7 (2), e157-e167
- https://doi.org/10.1016/s2352-3026(19)30256-x
Abstract
No abstract availableKeywords
Funding Information
- ERC (681012)
This publication has 70 references indexed in Scilit:
- Association between Calcineurin Inhibitor Blood Concentrations and Outcomes after Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2012
- A Retrospective Comparison of Tacrolimus versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation with Mobilized Blood CellsTransplantation and Cellular Therapy, 2011
- Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignanciesBlood, 2011
- Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomesBlood, 2009
- Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantationPublished by American Society of Hematology ,2006
- Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for hematological malignanciesBone Marrow Transplantation, 2005
- Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host diseaseTransplantation and Cellular Therapy, 2001
- PREDNISONE THERAPY FOR ACUTE GRAFT-VERSUS-HOST DISEASETransplantation, 1993
- Serum Cyclosporine Concentration and Risk of Acute Graft-versus-Host Disease after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1988
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986